Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.
about
Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosisChanges in frontal-parietal activation and math skills performance following adaptive number sense training: preliminary results from a pilot studyNeural correlates of cognitive improvements following cognitive remediation in schizophrenia: a systematic review of randomized trialsCognitive enhancement in schizophrenia: pharmacological and cognitive remediation approachesA debate on working memory and cognitive control: can we learn about the treatment of substance use disorders from the neural correlates of anorexia nervosa?Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice.The neural basis of theory of mind and its relationship to social functioning and social anhedonia in individuals with schizophrenia.Auditory working memory impairments in individuals at familial high risk for schizophrenia.Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia.L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study.Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?Feasibility and preliminary efficacy data from a computerized cognitive intervention in children with chromosome 22q11.2 deletion syndrome.Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: a longitudinal cohort study.A review of neuroimaging studies of young relatives of individuals with schizophrenia: a developmental perspective from schizotaxia to schizophrenia.Similar and different gray matter deficits in schizophrenia patients and their unaffected biological relativesNeuroimaging for psychotherapy research: current trendsNeuroplastic Changes Following Social Cognition Training in Schizophrenia: A Systematic Review.Computerized cognitive remediation therapy effects on resting state brain activity and cognition in schizophrenia.Effects of the mode of re-socialization after juvenile social isolation on medial prefrontal cortex myelination and function.Cognitive training in mental disorders: update and future directions.Harnessing neuroplasticity for clinical applications.Adolescent brain development, substance use, and psychotherapeutic change.Adjusting brain dynamics in schizophrenia by means of perceptual and cognitive trainingNeurobiology of cognitive remediation therapy for schizophrenia: a systematic reviewNeural disruption to theory of mind predicts daily social functioning in individuals at familial high-risk for schizophrenia.Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia.Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial.Maternal-fetal blood incompatibility and neuromorphologic anomalies in schizophrenia: Preliminary findingsCompensatory cognitive training for psychosis: who benefits? Who stays in treatment?GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia.Effects of Endurance Training Combined With Cognitive Remediation on Everyday Functioning, Symptoms, and Cognition in Multiepisode Schizophrenia Patients.Social impairment in schizophrenia: new approaches for treating a persistent problemLessons learnt? The importance of metacognition and its implications for Cognitive Remediation in schizophreniaCortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions.Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and SchizophreniaNeurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence.Is early intervention for psychosis feasible and effective?Neuroimaging studies of cognitive remediation in schizophrenia: A systematic and critical review.Cognitive Enhancement Therapy Improves Frontolimbic Regulation of Emotion in Alcohol and/or Cannabis Misusing Schizophrenia: A Preliminary Study
P2860
Q24187709-12B821BB-82B3-491D-92C7-8003454996DAQ24621340-05A13137-B85F-4181-8682-C40DCFBE59D0Q26753204-8E1751D3-6D9E-4B9A-B61E-3BC2C4032C59Q26864324-D1CE8721-8B9B-4D60-9D0B-D99B3A2F8FBDQ28602506-895469C8-8D6C-4131-AB85-C497C13AD94EQ30443234-9DFF2B3F-1012-431F-89A7-2D8F50A1AED2Q30445421-41C84E95-45D2-430E-8D84-633F2BD7978BQ30455072-361B62EF-057B-47EF-9ACF-A9F3439C0DBFQ30458900-FA9696E7-2A72-492E-8C82-FA9F46E8A32EQ30475497-5BC313B9-2CFE-4540-ABE5-D9A9C5E4B6AEQ30536299-AF7C5E71-CBB1-4A09-92BD-AB1D240AEC07Q30644398-CA4A1FBA-7A48-4BD8-98CB-6FC0288C814EQ30654007-27F6385C-1E46-48F9-AA50-608FB0F22884Q30678998-EC9CFAA1-3E96-40D8-B77A-59C780300E70Q30711211-80AB19FC-2DC0-4B7F-AB3B-1CD7F793AB4EQ30757175-9FC9FE79-D37C-44DE-97AC-EBAF18EF7C88Q31122502-16D8A472-90A5-468C-A4F3-7F7799EEBF84Q33881374-6CFFAB85-DD0B-44F1-8AAA-03BDA6F7569DQ33905934-A9AAD827-BEDB-48EF-BACB-79558C069902Q33965307-79EA13A7-4241-409C-A8AA-09291F9A2FFCQ34177415-2EAD57EF-B666-40E1-9BA6-28398E7B4FB2Q34316780-92D31139-544A-4374-A665-17C2ADBA8A01Q34344657-C5722F03-89A1-4E2C-917B-D4EC6C25C536Q34436237-4AFDBD46-9D16-4C91-A3A8-C476138C87E3Q34597118-6B0EE74F-4515-413F-A716-4E50347670CFQ34830625-D1A194D8-E911-43F8-A086-4905A244FAE3Q35019827-8597CA0C-03A6-47FE-B54F-F3D8E435DCBFQ35124178-A737FDF6-982E-47C0-AE74-FAA730AC35F9Q35176769-9AB2086F-4BB9-4729-8F2F-38C93A9E2A6AQ35469889-6F94750C-8F6B-4801-8DB1-BB3788113586Q35532688-D7CE8AD7-35EC-484D-8072-6747F30D31B2Q35739005-1B94ACFC-6960-47B9-BAC4-BCCA40A0E5A3Q35772056-16C8F58F-9EA2-43F9-B044-A7E5A5B3A19CQ36014100-25FEBB1D-70E5-4F25-9D55-CE7EC546F85FQ36059857-AD090E70-B822-40EE-9219-93C9A8258E05Q36063627-AE7D80BF-872F-4A08-BBB3-E12590A87DBEQ36169003-2CB8005D-52A8-4839-A6D2-59BAC4FA92ECQ36201294-E342C057-E033-4703-A2D3-FB04B3FDED0FQ36344132-E6E135DE-02CB-4BEF-9AEB-BC3542D38EECQ36452922-6F148E36-99D2-4C02-9119-2E65904B4F69
P2860
Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuroprotective effects of cog ...... r randomized controlled trial.
@en
Neuroprotective effects of cog ...... r randomized controlled trial.
@nl
type
label
Neuroprotective effects of cog ...... r randomized controlled trial.
@en
Neuroprotective effects of cog ...... r randomized controlled trial.
@nl
prefLabel
Neuroprotective effects of cog ...... r randomized controlled trial.
@en
Neuroprotective effects of cog ...... r randomized controlled trial.
@nl
P2093
P2860
P1433
P1476
Neuroprotective effects of cog ...... r randomized controlled trial.
@en
P2093
Deborah P Greenwald
Gerard E Hogarty
Konasale M R Prasad
Raymond Y Cho
Shaun M Eack
Susan S Hogarty
P2860
P304
P356
10.1001/ARCHGENPSYCHIATRY.2010.63
P407
P577
2010-05-03T00:00:00Z